Hybrid SPECT/CT Imaging in Neurology

ISSN: 1874-4729 (Online)
ISSN: 1874-4710 (Print)

Volume 8, 2 Issues, 2015

Download PDF Flyer

Current Radiopharmaceuticals

Aims & ScopeAbstracted/Indexed in

Submit Abstracts Online Submit Manuscripts Online

Sean L. Kitson
Current Radiopharmaceuticals
Almac Sciences
Almac House
20 Seagoe Industrial Estate
Craigavon, BT63 5QD
Northern Ireland

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Hybrid SPECT/CT Imaging in Neurology

Current Radiopharmaceuticals, 7(1): 5-11.

Author(s): Andrea Ciarmiello, Elisabetta Giovannini, Martina Meniconi, Vincenzo Cuccurullo and Maria Chiara Gaeta.

Affiliation: Nuclear Medicine Department, S. Andrea Hospital, Via Vittorio Veneto, 197, 19124 La Spezia, Italy.


In recent years, the SPECT/CT hybrid modality has led to a rapid development of imaging techniques in nuclear medicine, opening new perspectives for imaging staff and patients as well. However, while, the clinical role of positron emission tomography-computed tomography (PET-CT) is well consolidated, the diffusion and the consequent value of single-photon emission tomography-computed tomography (SPECT-CT) has yet to be weighed, Hence, there is a need for a careful analysis, comparing the "potential" benefits of the hybrid modality with the "established" ones of the standalone machine.

The aim of this article is to analyze the impact of this hybrid tool on the diagnosis of diseases of the central nervous system, comparing strengths and weaknesses of both modalities through the use of SWOT analysis.


Alzheimer, Brain tumors, Hybrid Imaging, Neurology, Nuclear Medicine, Spect/CT.

Download Free Order Reprints Order Eprints Rights and Permissions

Article Details

Volume: 7
Issue Number: 1
First Page: 5
Last Page: 11
Page Count: 7
DOI: 10.2174/1874471007666140821152401

Related Journals

Webmaster Contact: urooj@benthamscience.org Copyright © 2015 Bentham Science